|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2007-6-29
|
|
pubmed:abstractText |
Barbiturate coma is the second tier measure recommended by guidelines to treat post-traumatic refractory intracranial pressure. Systemic hypotension is its most important side effect. Recent evidence suggests that low-dose corticosteroid therapy may be used in a subset of patients with traumatic brain injury (TBI) to avoid hypotension. We evaluated adrenal function in TBI patients undergoing barbiturate coma, as treatment of their refractory intracranial hypertension.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
1720-8386
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
30
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
393-8
|
|
pubmed:meshHeading |
pubmed-meshheading:17598971-Adrenal Glands,
pubmed-meshheading:17598971-Adrenal Insufficiency,
pubmed-meshheading:17598971-Adult,
pubmed-meshheading:17598971-Barbiturates,
pubmed-meshheading:17598971-Brain Injuries,
pubmed-meshheading:17598971-Coma,
pubmed-meshheading:17598971-Female,
pubmed-meshheading:17598971-Humans,
pubmed-meshheading:17598971-Hydrocortisone,
pubmed-meshheading:17598971-Hypotension,
pubmed-meshheading:17598971-Intracranial Hypertension,
pubmed-meshheading:17598971-Male,
pubmed-meshheading:17598971-Middle Aged,
pubmed-meshheading:17598971-Norepinephrine,
pubmed-meshheading:17598971-Prospective Studies,
pubmed-meshheading:17598971-Sympathomimetics,
pubmed-meshheading:17598971-Trauma Severity Indices
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Effect of barbiturate coma on adrenal response in patients with traumatic brain injury.
|
|
pubmed:affiliation |
Intensive Care Medicine Service, Son Dureta University Hospital, Palma de Mallorca, Spain. jallompart@hsd.es
|
|
pubmed:publicationType |
Journal Article,
Controlled Clinical Trial
|
